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Abstract
Background: Asymptomatic, low parasite density malaria infections are difficult to detect with currently available
point-of-care diagnostics. This study piloted a loop-mediated isothermal amplification (LAMP) kit for field-friendly,
high-throughput detection of asymptomatic malaria infections during mass screening and treatment (MSAT) in
Zanzibar, a malaria pre-elimination setting.
Methods: Screening took place in three known hotspot areas prior to the short rains in November. Finger-prick
blood was taken for screening by rapid diagnostic test (RDT) and LAMP and collected on filter paper for subsequent
polymerase chain reaction (PCR) analyses. LAMP results were compared to RDT and to PCR using McNemar’s test.
Results: Approximately 1,000 people were screened. RDT detected ten infections (1.0% (95% CI 0.3-1.6)) whilst both
LAMP and PCR detected 18 (1.8% (95% CI 0.9-2.6)) infections. However, PCR identified three infections that LAMP
did not detect and vice versa. LAMP testing was easy to scale-up in field conditions requiring minimal training and
equipment, with results ready one to three hours after screening.
Conclusions: Despite lower than expected prevalence, LAMP detected a higher number of infections than the
currently used diagnostic, RDT. LAMP is a field-friendly, sensitive diagnostic test that could be useful for MSAT
malaria campaigns which require quick results to enable prompt treatment.
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Background
Asymptomatic and low-density malaria infections are a
challenge for areas targeting elimination. Surveillance
systems, which are a vital part of malaria elimination
efforts, tend to be designed to focus on symptomatic
infections captured through routine health systems.
However, data suggest that the asymptomatic parasite
reservoir can form the majority of infections when mal-
aria transmission is low [1] and contribute substantially
to transmission [2,3].
In Zanzibar, where malaria surveillance systems are in
place in public health facilities, approximately 1% of
febrile patients are confirmed malaria positive (using
malaria rapid diagnostic test (RDT) or microscopy) [4].
RDTs have demonstrated their utility in a healthcare set-
tings in Zanzibar [5], where parasite densities are likely
to be higher as they have induced symptoms, but com-
munity studies suggest they are not effective for de-
tecting asymptomatic, often low-density infections [6].
Molecular tests, such as polymerase chain reaction (PCR)
have demonstrated higher sensitivities [7] but are not
ideal for point-of-care diagnosis due to the need for ad-
vanced laboratory conditions, high cost and relatively
long time to results.
Mass screening and treatment (MSAT) is an interven-
tion designed to detect malaria infections in the commu-
nity. These often asymptomatic and low-density infections
are unlikely to present at health facilities and require ultra-
sensitive, high-throughput, field-friendly point-of-care
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diagnostic tools to detect them in order to successfully
reduce subsequent transmission.
Loop-mediated isothermal amplification (LAMP) of-
fers a field-friendly alternative to PCR. LAMP is less
time intensive than PCR and can be performed using
heat-blocks, with results read by eye under UV light. It
has been successfully developed to detect malaria in a
field-stable format [8-10]. The Loopamp™ MALARIA
Pan/Pf kit has been trialled in Europe [11,12] and in a
health facility setting in Uganda [13], but not in the
high-throughput manner required for MSAT. This study,
based in Zanzibar, aimed to pilot the kit as the diagnostic
tool in a routine MSAT intervention and to assess its prac-
ticality and performance for detection of malaria infection
compared to RDT and PCR.
Methods
Study site and population
Zanzibar is a semi-autonomous archipelago, located
35 km from the coast of mainland Tanzania. Malaria
transmission is low, equivalent to a state of pre-
elimination. It is seasonal and focal, with the majority of
the cases occurring after the long rains in March to May
[4]. Short rains occur in November and December. The
study took place over 1 week in November 2013 and
aimed to screen 1,000 participants from three areas of
residual seasonal malaria foci in Unguja island (Panga
Tupu, Ukongoroni and Zingwezingwe) where increased
malaria incidence had been recorded during the 2013 rainy
season.
The communities of the study areas (total popula-
tion ~1,900) were sensitized to the aims of the study
by local chiefs and were asked to report to their local
health facility or school for screening on pre-determined
dates. All willing participants who reported to the screen-
ing points and provided informed consent were tested,
regardless of symptoms.
Sample collection and diagnostics
Screening took place over one or two days in each area.
Data collection took place on Nexus 7 tablets using forms
designed in Open Data Kit [14]. At screening, blood sam-
ples for three different malaria diagnostics were taken from
a single finger-prick: 5 μl for RDT (using the collection de-
vice provided in the kit), 60 μl for LAMP (using a plastic
capillary tube (Dropstir, Medical Precision Plastics, USA))
and approximately 50 μl spotted directly onto filter paper
(Whatman 3MM) for PCR.
RDT
The RDT used in the study was SD Bioline malaria
Ag-Pf/pan (Standard Diagnostics Ref 05FK60, Inc;
Suwon City, Republic of Korea), targeting Plasmodium
falciparum-specific histidine-rich protein-2 (HRP-2) and
Pan-Plasmodium lactate dehydrogenase (pLDH). The test
was used in accordance with manufacturer’s instructions.
Individuals found positive by RDT were treated using
artesunate-amodiaquine, i.e., first-line treatment for un-
complicated malaria, as per national guidelines.
LAMP
Sixty μl of finger-prick blood was dispensed into a pre-
labelled and pre-aliquoted 1.5-ml microtube containing
60 μl of DNA extraction buffer (400 nM NaCl, 40 mM
Tris pH 6.5, 0.45 SDS).
DNA extraction
DNA was extracted by the boil and spin method [13].
Briefly, the tubes containing blood and extraction buffer
were vortexed and placed in a heat-block at 95°C for
5 min. The tubes were then centrifuged at 10,000 g for
3 min and 30 μl of the supernatant transferred to a tube
containing 345 μl of sterile water.
Loopamp MALARIA Pan/Pf detection kit
The LAMP assay was performed using Loopamp™
MALARIA Pan Detection Kit (Eiken Chemical Company,
Japan) [15]. The Loopamp kit has been described in detail
previously [13]. Briefly, 30 μl of diluted DNA extraction
was added to each Pan-LAMP tube. Samples were
screened in batches of 46 samples (the maximum number
of tubes that would fit on the heat-block) and a positive
and negative control was included in each run. Following
inversion and mixing of the tubes, the strips were placed in
a heat-block at 65°C for 40 min, and then transferred for
2 min at 95°C for enzyme inactivation. The results were
read immediately by eye under a UV light. All individuals
positive for Pan-LAMP were then retested using Pf-LAMP
specific kits. Positive individuals (who were not positive by
RDT) were informed about their results and given treat-
ment within three hours of screening.
Two heat-blocks (95°C and 65°C), a UV lamp and one
centrifuge (24×1.5 ml tubes) were required for LAMP
testing. The extraction and the LAMP assays were per-
formed in separate areas to avoid any risk of contamin-
ation, however, the heat-block set at 95°C was used for
both the DNA extraction and the enzyme inactivation
steps. All LAMP tubes were immediately discharged in
safety boxes after detection of result. All samples were
processed on the same day as sampling.
PCR
Filter papers were air-dried and packaged in individual
sealable bags containing desiccant before being trans-
ported to Sweden for PCR analysis. DNA was extracted
with the Chelex-100 method using one filter paper punch
(3–5 μl) [16]. All samples were screened for parasite DNA
with a SYBR Green real-time PCR assay, targeting the
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Cytochrome b gene of the four major human Plasmodium
species. The real-time PCR results were analysed by melt-
ing curve and gel electrophoresis. PCR products were
digested by FspBI enzyme (Thermo Fisher, USA) in RFLP
assay for species identification (Weiping Xu, unpublished
material). Samples with discordant results between Pan/Pf-
LAMP versus PCR or RDT were re-extracted in duplicate
and each extraction was repeated by PCR in duplicate
(=four PCRs). All PCR-positive samples were quantified
with an 18S rRNA PCR [17] against standards of known
parasite densities.
Staff training and logistics
Two laboratory technicians employed by Zanzibar Malaria
Elimination Programme with no previous experience of
LAMP and limited experience of molecular methods were
trained for three days to perform DNA extraction and the
LAMP assay. Four enumerators were trained to record in-
formation on the tablet computers, to take blood and to
use and interpret the RDT. Sample collection took place in
two health facilities (Zingwezingwe and Ukongoroni) and a
school hall (Panga Tupu). DNA extraction and LAMP took
place in small rooms within health facilities. LAMP
samples from Panga Tupu were transported at ambient
temperature 1 km by car to a nearby health facility,
equipped with electricity, for processing.
Data analysis
This was an explorative study to test LAMP in a high-
throughput manner as well as determine its sensitivity
and specificity. The study aimed to screen 1,000 partici-
pants. Based on previous molecular studies in Zanzibar
[6], it was estimated that this sample size would detect
approximately five RDT positives and up to 40 LAMP
positives. Data were downloaded from the Nexus 7 tab-
lets into STATA v12 (Statacorp, Texas, USA). The diag-
nostic performance was assessed by calculating the
sensitivity and specificity of RDT and LAMP using
Cytochrome-b PCR as the reference standard and assessed
using McNemar’s test.
Ethical issues
Written informed consent was obtained from all partici-
pants or guardians. Ethical approval was obtained from
the Zanzibar Medical Ethical Committee (ZAMEC)
(ZAMREC/0001/September/013) and from the Regional
Ethics Review Board, Stockholm, Sweden (2013/836-32).
Results
Study population
Approximately 250 samples were processed per day. A
total of 996 samples had matching RDT, LAMP and PCR
results: 271, 422 and 303 from Panga Tupu, Ukongoroni
and Zingwezingwe, respectively. This represented 81, 51
and 41% of the estimated populations of each area. The
median age of participants was 12 years old (range:
one month to 95 years) and 54% of people screened were
female.
Practicality of sample collection and processing of LAMP
On the whole, the process was simple and the enumerators
and lab technicians experienced few problems. Some diffi-
culty was experienced using the plastic capillary tube and
obtaining the full volume of blood required, however, the
enumerators were able to improve their technique with
practice. The DNA extraction and LAMP test were simple
to perform and no bottlenecks were experienced at any
stage of the process, although a higher number of samples
per day would have been difficult to process with just one
LAMP station. The readings of LAMP results via UV light
were easy to perform with good inter-observer agreement.
All Pan-LAMP results were available within 3 hours of
sample collection. Pf-LAMP was run on all Pan-LAMP
positives at the end of each day.
Malaria indices
Overall 10/997 (1.0% (95% CI, 0.1-8.1%) individuals were
RDT positive, whereas both Pan-LAMP and cyt-b PCR de-
tected 18/997 (1.8% (0.2-18.0%) malaria infections (Table 1).
All RDT positives were confirmed by PCR, but one RDT
positive was not positive by LAMP (Figure 1). Three of the
Pan-LAMP positive samples were not confirmed by PCR.
Nine of the Pan-LAMP positive samples were also positive
for Pf-LAMP (Table 1).
Using PCR as the reference standard, RDT detected
approximately half of the infections, with a sensitivity of
55.6% (30.8-78.5%) whilst Pan-LAMP detected approxi-
mately 4/5ths of the PCR determined infections with a
corresponding LAMP sensitivity of 83.3% (58.6-96.4%)
(McNemar’s test: p = 0.06). Both RDT and LAMP had
specificities over 99% against PCR.
Of 18, 15 (83%) of the PCR positive samples were
P. falciparum, one was Plasmodium malariae, and the
remaining two had unsuccessful species determination
(Table 2). The real-time PCR determined P. falciparum
geometric mean density was 26 parasites/μl (range: 0–
4,626). The corresponding mean parasite densities were
47 parasites/μl (range 0–4,626) and 661 parasites/μl
(range 2–4,626), respectively, for Pan-LAMP and RDT
positive samples. The three Pf-LAMP-negative but PCR-
positive P. falciparum infections had parasite densities of 3,
24 and 293 parasites/μl, all these were, however, positive by
Pan-LAMP and the highest density (293 parasites/μl) was
also positive by RDT.
Discussion
Highly sensitive, field-friendly diagnostics are required
to enable prompt detection and treatment of low-density
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Table 1 Results, sensitivity and specificity of LAMP (Pan and Plasmodium falciparum) and RDT by screening site
Method Positive no. Negative no. Sensitivity, % (95% CI) Specificity, % (95% CI)
Total
PCR 18 (15 Pf, 1 Pm, 2 undetermined) 978 Reference
Pan-LAMP 18 978 83.3 (58.6-96.4) 99.7 (99.1-99.9)
Pf-LAMP¤ 9 9 60.0 (32.3-83.7)
RDT 10 996 55.6 (30.8-78.5) 100 (99.6-100)
Panga Tupu
PCR 11 (9 Pf, 2 undetermined) 260 Reference
Pan-LAMP 11* 260 81.8 (48.2-97.7) 99.2 (97.2-99.9)
Pf-LAMP¤ 6 5 66.7 (29.9-92.5)
RDT 5 266 45.5 (16.7-76.6) 100 (98.6-100)
Ukongoroni
PCR 1 (Pf) 421 Reference
Pan-LAMP 2 420 100 (2.5-100) 99.8 (98.7-100)
Pf-LAMP¤ 1 1 100 (2.5-100)
RDT 1 421 100 (2.5-100) 100 (99.1-100)
Zingwezingwe
PCR 6 (5 Pf, 1Pm) 297 Reference
Pan-LAMP 5** 298 83.3 (35.9-99.6) 100 (98.8-100)
Pf-LAMP¤ 2 4 40.0 (5.3-85.3)
RDT 4 299 66.7 (22.3-95.7) 100 (98.8-100)
*2 not confirmed by PCR (Pf-LAMP negative).
**1 not confirmed by PCR (Pf-LAMP negative).
¤Pf LAMP only performed on Pan-LAMP positives so true specificity cannot be determined.
Figure 1 Venn diagram showing the distribution of positive RDT, Pan-LAMP and PCR results.
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malaria infections during routine MSAT in low trans-
mission areas. The Loopamp™ MALARIA Pan Detection
Kit was simple to scale up for relatively high-throughput
screening in a field setting, requiring just three days of
training for staff with no previous experience of LAMP
and limited experience of molecular methods. Results
were available within one to three hours of screening and
showed similar high sensitivities as were demonstrated in
Uganda and in reference laboratories in Europe [11,18].
However, if LAMP is going to be a useful tool in routine
MSAT interventions in areas aiming at malaria elimination,
there is a need for even higher throughput (i.e. fewer trans-
fer steps, ability to run more samples simultaneously) for
screening of larger numbers of samples.
Pan-LAMP detected three positive samples that were
not confirmed using PCR. This is not uncommon with a
test that has a similar detection threshold as the refer-
ence standard and was also seen in a previous study in
Uganda [13]. Previous studies have questioned whether
this is due to false-positive LAMP or chance discrepancy
due to the low parasite density [11]. Conversely, three
PCR-positive infections were not confirmed using Pan-
LAMP. Importantly, these three samples all had parasite
densities lower than five parasites/μl. In addition, the Pf-
LAMP test did not detect several P. falciparum infec-
tions detected by Pan-LAMP, perhaps due to a lower
detection limit (5 versus 7.5 DNA copies/test) [12], al-
though one sample had approximately 300 parasites/μl.
With such low numbers of positive samples it is difficult
to make any conclusions about the Pf-LAMP, however
in Zanzibar, with a majority of infections being either
P. falciparum and/or P. malariae it may be pertinent
to solely use Pan-LAMP for screening purposes during
MSAT.
The prevalence of low density infections in the screen-
ing areas were lower than expected, based on previous
molecular studies in Zanzibar [6], which have detected
up to an eight-fold higher prevalence using PCR com-
pared to RDT/microscopy. The study sites were selected
based on higher than average incidence of symptomatic
cases reported to health facilities during the long rains
in March to May 2013. This highlights the complex
spatial and temporal dynamics of hotspots of transmis-
sion in a malaria pre-elimination setting. Despite the low
prevalence, there was some evidence that LAMP de-
tected a higher proportion of infections present than the
currently used tool. It is likely that if prevalence had
been higher, this result would have statistically signifi-
cant and in epidemiological terms, it remains important.
The use of LAMP during MSAT is likely to result in
a larger number of infections being treated, however,
whether this will result in lowered transmission is still to
be fully evaluated.
Conclusion
Currently, the Loopamp™ MALARIA Pan Detection Kit
is more expensive and less simple than RDT and thus
unlikely to be rolled out for use in health facilities
in Zanzibar, where malaria RDT is a reasonably cost-
effective tool to detect symptomatic, generally higher
parasite density, infections. However, the need for more
sensitive diagnostics during routine MSAT interventions
in low-endemic settings is clear. LAMP is a simple, sen-
sitive, field-friendly diagnostic which can be performed
outside of laboratory conditions and which could play
an important role in MSAT for improved detection and
treatment of low-density parasitaemias in order to re-
duce post-intervention malaria transmission.
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